Ryman Healthcare Limited
Ryman Healthcare Limited (RHCGF) Revenue
Annual & quarterly revenue history · segment & region breakdown
RHCGF · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsRyman Healthcare Limited trailing twelve-month (TTM) revenue is $1.54B, an increase of 12.99% year-over-year from $0.81B in FY2026.
Revenue trend
2026 – 2007 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2026-03-31 | $0.81B | +$0.09B | +12.99% |
| 2025-03-31 | $0.71B | +$0.06B | +9.72% |
| 2024-03-31 | $0.65B | +$0.09B | +16.14% |
| 2023-03-31 | $0.56B | +$0.06B | +11.19% |
| 2022-03-31 | $0.50B | +$0.05B | +11.35% |
| 2021-03-31 | $0.45B | +$0.03B | +7.18% |
| 2020-03-31 | $0.42B | +$0.04B | +10.56% |
| 2019-03-31 | $0.38B | +$0.04B | +11.61% |
| 2018-03-31 | $0.34B | +$0.05B | +18.48% |
| 2017-03-31 | $0.29B | +$0.03B | +10.90% |
Compare revenue vs peers
Medical - Care FacilitiesCompare RHCGF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Ryman Healthcare Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Ryman Healthcare Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in NZD.
Data sourced from Ryman Healthcare Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
RHCGF revenue · 4 questionsRHCGF's trailing twelve-month (TTM) revenue is $1.54B. That is an increase of 12.99% year-over-year from $0.81B in FY2026.
▸ Source: FMP · Ryman Healthcare Limited SEC filings · GAAP · Ryman Healthcare Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026